Table 4 Quality of life
BaselineInterventionControlDifference (95% CI)p Value
SGRQ
Intention-to-treat (n = 41)(n = 23)(n = 18)
    Activity73.470.478.78.3 (−17.3 to 0.5)0.06
    Impacts43.535.452.817.4 (−28.8 to −6.1)0.004
    Symptoms60.659.561.62.1 (−14.4 to 10.3)0.73
    Total55.351.261.310.1 (−18.5 to −1.7)0.02
Completed study (n = 37)
6 months(n = 20)(n = 17)
    Activity74.867.0 (3.3)80.4 (3.5)13.4 (−23.3 to −3.6)0.009
    Impacts46.142.3 (2.8)48.5 (3.0)6.2 (−14.5 to 2.2)0.14
    Symptoms62.863.2 (2.4)66.6 (2.5)3.4 (−10.4 to 3.7)0.34
    Total57.653.4 (2.2)61.1 (2.4)7.7 (−14.4 to −1.1)0.02
12 months
    Activity75.469.3 (2.9)†80.5 (3.0)11.2 (−19.8 to −2.7)0.01
    Impacts47.035.8 (3.3)†53.7 (3.5)‡17.9 (−27.6 to −8.2)0.001
    Symptoms62.863.4 (4.4)†63.8 (4.5)0.4 (−13.3 to 12.5)0.95
    Total58.250.6 (2.7)†63.9 (2.8)‡13.3 (−21.3 to −5.4)0.002
Short Form-36
Intention-to-treat (n = 41)(n = 23)(n = 18)
    Health change34.851.7 (5.6)32.5 (6.4)19.2 (2.0 to 36.4)0.029
Completed study (n = 37)
6 months(n = 19)§(n = 17)
    Health change35.453.8 (4.8)29.6 (5.0)24.2 (10.1 to 38.3)0.001
12 months(n = 18)¶(n = 16)¶
    Health change33.855.2 (5.7)28.5 (6.1)26.7 (9.7 to 43.7)0.003
  • Values are adjusted for baseline measurements and expressed as means (SE); Difference: difference in measurements between intervention and control groups; 95% confidence interval (CI) for the difference between intervention and control groups; p values for ANCOVA tests between intervention and control groups.

  • St George’s Respiratory Questionnaire (SGRQ): scores range from 0 (perfect health) to 100 (worst possible health);†n = 18 (two patients refused to complete SGRQ at 12 months); ‡n = 16 (one patient failed to complete the Impacts section of SGRQ at 12 months).

  • SF-36: scores range from 0 (worst possible health) to 100 (perfect heath); §one patient refused to complete the SF-36 at 6 months and another at 12 months; ¶two patients refused to complete the SF-36 at 12 months.